BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 13, 2026

Jan. 13, 2026
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hutchmed, Incyte Biosciences, Kahr Medical, Nanjing Delova Biotech
Read More

In the clinic for Jan. 12, 2026

Jan. 12, 2026
Clinical updates, including data readouts and publications: Acousia, Clarametyx, Eli Lilly, Enyo, Innovent, Krystal, Krystal, Zyus.
Read More

In the clinic for Jan. 9, 2026

Jan. 9, 2026
Clinical updates, including data readouts and publications: Agomab, Antag, Biovaxys, Coya, Enliven, Enterobiotix, Epicrispr, Epirium, Eupraxia, Imbria, Kahr, Renovorx, Reviva, Sobi, Sustained, Tvardi, Virometix.
Read More

In the clinic for Jan. 9, 2026

Jan. 9, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Omanda Health, Skylinedx.
Read More

In the clinic for Jan. 8, 2026

Jan. 8, 2026
Clinical updates, including data readouts and publications: Bridgebio, Genfit, Gilgamesh, GSK, Hutchmed, Jazz, JJP Biologics, Monte Rosa, Pulmocide, Rezolute.
Read More

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including data readouts and publications: Aclaris, Actuate, Alumis, Apogee, Arrowhead, Astrazeneca, Bright Minds, Cognition, Compass, Demerx, Encellin, Huyabio, Idorsia, Iksuda, Johnson & Johnson, Metavia, Nanjing Delova, Novabridge, Seres.
Read More

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sera Prognostics.
Read More

In the clinic for Jan. 6, 2026

Jan. 6, 2026
Clinical updates, including data readouts and publications: Bioinvent, Crinetics, Incyte, Marker, Neumora, Soleno, Zenas.
Read More

In the clinic for Jan. 6, 2026

Jan. 6, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cumulus Neuroscience, Freenome Holdings, Hyperfine, Linus Health, Ventric Health.
Read More

In the clinic for Jan. 5, 2026

Jan. 5, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Setpoint Medical.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 317 318 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 6, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing